Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genmab
Biotech
Genmab axes 3 programs to focus on plumped-up pivotal pipeline
The biotech is axing three early-stage clinical programs to accelerate investment in its recently expanded phase 3 pipeline.
Nick Paul Taylor
Nov 7, 2024 5:41am
BioMarin builds exec team with biotech vets—Chutes & Ladders
Aug 23, 2024 8:30am
BioNTech ends work on Genmab-partnered bispecific antibody
Aug 5, 2024 7:50am
Genmab inks $1.8B ProfoundBio buyout for would-be Elahere rival
Apr 3, 2024 5:32am
Genmab's growth plan entails partnering less, owning more: CEO
Mar 14, 2024 9:40am
Argenx, Genmab join forces to expand into new therapeutic areas
Apr 17, 2023 6:20am
